Lipodystrophy syndrome and self-assessment of wellbeing and physical appearance in HIV-positive patients
1 November 2002. Related: Side effects, Lipodystrophy and metabolic complications.
2002
Multivitamins limit HIV transmission through breastfeeding for some women
1 November 2002. Related: Other news.
Lymphoma in the setting of HIV disease
1 November 2002. Related: On the web.
Mitochondrial toxicity in HAART
1 November 2002. Related: On the web.
Mechanisms of T-cell depletion and repletion in HIV disease
1 November 2002. Related: On the web.
HAART interruption strategies: how, when & why?
1 November 2002. Related: On the web.
HIV/AIDS related Spanish language sites, from thirteen different countries.
1 November 2002. Related: On the web.
New treatment information from Visionary Health Concepts
1 November 2002. Related: On the web.
The Guide to Lipodystrophy in HIV
1 November 2002. Related: On the web.
LIPOWatch
1 November 2002. Related: On the web.
Fat in the blood
1 November 2002. Related: On the web.
Current status of ARV treatment interruption and intermittent therapy strategies
1 November 2002. Related: On the web.
Pathogenesis and epidemiology of metabolic abnormalities
1 November 2002. Related: On the web.
Management of morphologic changes during antiretroviral therapy: insights from etiology
1 November 2002. Related: On the web.
Entry inhibitors
1 November 2002. Related: On the web.
Mitochondrial toxicity
1 November 2002. Related: On the web.
HIV medicine after the Barcelona conference: interview with Howard Grossman MD
1 November 2002. Related: On the web.
Once-daily antiretroviral options
1 November 2002. Related: On the web.
Volume 3 Number 9 November 2002 PDF
1 November 2002. Related: PDFs.
Excitement over anticipated approval of T-20 is balanced by fears that it will be the most expensive HIV drug yet
13 October 2002. Related: Treatment access.
GlaxoSmithKline cuts drug prices to 63 countries
13 October 2002. Related: Treatment access.
Integrase inhibitors enter trials in human volunteers
13 October 2002. Related: Other news.
US HIV community hold productive meeting with Schering-Plough on new anti-HIV entry inhibitors SCH-C and SCH-D
13 October 2002. Related: Antiretrovirals.
Notes on Schering-Plough/HIV community meeting held August 28 2002
13 October 2002. Related: Antiretrovirals.
US FDA announces important changes in amprenavir product labelling
13 October 2002. Related: Antiretrovirals, PK and drug interactions.
Antiretrovirals could stop HIV epidemic – optimism or realism?
13 October 2002. Related: Other news.
Much lower dose of lamivudine needed for HIV-positive patients on dialysis
13 October 2002. Related: Antiretrovirals.
M184V is associated with decreased development of TAMs
13 October 2002. Related: Drug resistance.
Patients discontinuing HAART must be carefully monitored
13 October 2002. Related: Antiretrovirals.
Antiretrovirals have neurologic benefits in children
13 October 2002. Related: Paediatric care.
Early data highlight ribavirin’s anti-adenovirus potential
13 October 2002. Related: Paediatric care.
Updated recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States
13 October 2002. Related: Guidelines.
St John’s Wort interferes with chemotherapy, study shows
13 October 2002. Related: PK and drug interactions, Cancer and HIV.
Dutch researchers theorise chimpanzees may have survived AIDS epidemic two million years ago
13 October 2002. Related: Other news.
Majority of HIV patients in San Francisco study use alternative medicines
13 October 2002. Related: Other news.
Early data find HIV patients do well with organ transplants
13 October 2002. Related: Other news.
Thai charity ditches V-1 Immunitor
13 October 2002. Related: Other news.
ABC of psychological medicine: fatigue
13 October 2002. Related: On the web.
Initial antiretroviral therapy: further insights on when to start and what to use
13 October 2002. Related: On the web.
Antiretroviral therapy in treatment-experienced patients
13 October 2002. Related: On the web.
Update on lipodystrophy…or is it just lipoatrophy?
13 October 2002. Related: On the web.
Opportunistic infections and coinfections: focus on fungi and hepatitis
13 October 2002. Related: On the web.
XI International HIV Drug Resistance Workshop: basic principles and clinical implications; Seville, Spain July 2-5, 2002
13 October 2002. Related: On the web.
Time for T
13 October 2002. Related: On the web.
CD4 cell depletion in AIDS: models for novel therapies
13 October 2002. Related: On the web.
FRAM study and lipodystrophy: lipodystrophy study presented at Barcelona and an interview with the study author Carl Grunfeld
13 October 2002. Related: On the web.
Volume 3 Number 8 October 2002 PDF
1 October 2002. Related: PDFs.
XI International HIV Drug Resistance Workshop, Seville, 2-5 July, 2002
11 September 2002. Related: Conference reports.
Short resistance reports from Seville
11 September 2002. Related: Conference reports, Drug resistance.
New anti-HIV compounds discussed at the Seville HIV Drug Resistance Workshop and the Barcelona World AIDS Conference
11 September 2002. Related: Conference reports, Antiretrovirals.
Review of phenotypic resistance testing data presented at the XI International HIV Drug Resistance Workshop
11 September 2002. Related: Conference reports, Drug resistance.
XIV International AIDS Conference Barcelona, 7-12 July 2002
11 September 2002. Related: Conference reports.
Bill Clinton and Nelson Mandela promise to lead peer education among political leaders as world looks for $10 billion a year to fight HIV/AIDS
11 September 2002. Related: Conference reports, Treatment access.
South African activist unveils campaign to force compulsory licences
11 September 2002. Related: Conference reports, Treatment access.
MSF study shows treatment in resource-poor settings is effective
11 September 2002. Related: Conference reports, Treatment access.
‘Barcelona Declaration’ demands 2m poor people are treated in the next two years
11 September 2002. Related: Conference reports, Treatment access.
Lives were lost as experts argued the merits of care versus prevention, says Stefano Vella
11 September 2002. Related: Conference reports, Treatment access.
Peter Piot sets out the global political agenda in the fight against HIV/AIDS
11 September 2002. Related: Conference reports, Treatment access.
Health should be a right, not a commodity, and medicine must be removed from the World Trade Organisation, argues key speaker
11 September 2002. Related: Conference reports, Treatment access.
Governments must act to cut drug prices, says Kenya’s health minister
11 September 2002. Related: Conference reports, Treatment access.
Civil society had to fight for universal access to AIDS drugs in Brazil
11 September 2002. Related: Conference reports, Treatment access.
Coalitions of local NGOs can effectively demand access to medicines, reports MSF
11 September 2002. Related: Conference reports, Treatment access.
Involvement of PLWHA is key to improving access to treatments
11 September 2002. Related: Conference reports, Treatment access.
ART can successfully tackle advanced disease in resource poor settings, reports MSF
11 September 2002. Related: Conference reports, Treatment access.
Investment in treatment and care significantly reduces company health and social expenditure in Abidjan
11 September 2002. Related: Conference reports, Treatment access.